FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental pharmacology and gastroenterology and concerns prevention of gastroesophageal reflux in experiment. Gastroesophageal reflux is modelled by single introduction of methylene blue into an animal's cardiac orifice. The preliminary introduction of the preparation L-NAME in a dose 1-5 mg/kg inhibits the development of gastroesophageal reflux.
EFFECT: method prevents the development of gastroesophageal reflux in experiment within a week after the single introduction of L-NAME in said dosage range.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CLINICAL COURSE PREDICTION OF GASTROESOPHAGEAL REFLUX | 2007 |
|
RU2346652C1 |
METHOD FOR MODELING GASTROESOPHAGEAL REFLUX DISEASE | 2004 |
|
RU2269162C1 |
METHOD FOR MODELING NONSPECIFIC ULCERATIVE COLITIS CASES | 2006 |
|
RU2316055C1 |
METHOD FOR ENTERO- AND PANCREACTOPROTECTIVE ACTION OF NON-STEROID ANTI-INFLAMMATORY PREPARATIONS | 2012 |
|
RU2545446C2 |
METHOD OF EARLY DIAGNOSTICS OF GASTROESOPHAGEAL REFLUX DISEASE IN PATIENTS WITH OBESITY | 2008 |
|
RU2373866C1 |
METHOD FOR MODELING PYLOROSTENOSIS | 2006 |
|
RU2321075C1 |
METHOD OF SYSTEMIC FIBROSIS MODELLING | 2008 |
|
RU2371778C1 |
METHOD FOR TREATMENT OF STOMACH AND DUODENUM ULCEROUS DISEASE | 2003 |
|
RU2240119C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE OF CHRONIC HEPATITIS AND HEPATIC CIRRHOSIS OF ALCOHOLIC AETIOLOGY | 2011 |
|
RU2477482C1 |
METHOD OF GASTRIC ULCER PREVENTION | 2007 |
|
RU2328286C1 |
Authors
Dates
2010-04-27—Published
2008-08-01—Filed